Lifeway Foods, Inc. (LWAY) Reaches $6.53 52-Week Low; Cree Has 1.1 Sentiment

March 14, 2018 - By Nellie Frank

The stock of Lifeway Foods, Inc. (NASDAQ:LWAY) hit a new 52-week low and has $6.20 target or 5.00% below today’s $6.53 share price. The 5 months bearish chart indicates high risk for the $104.64M company. The 1-year low was reported on Mar, 14 by If the $6.20 price target is reached, the company will be worth $5.23 million less. The stock decreased 1.51% or $0.1 during the last trading session, reaching $6.53. About 15,271 shares traded. Lifeway Foods, Inc. (NASDAQ:LWAY) has risen 8.00% since March 14, 2017 and is uptrending. It has underperformed by 8.70% the S&P500.

Cree, Inc. provides lighting-class light emitting diode , lighting, and semiconductor products for power and radio-frequency (RF) applications in the United States, China, Europe, South Korea, Japan, Malaysia, Taiwan, and internationally. The company has market cap of $4.21 billion. The Company’s Lighting Products segment offers LED lighting systems and bulbs for use in settings, such as office and retail space, restaurants and hospitality, schools and universities, manufacturing, healthcare, airports, municipal, residential, street lighting and parking structures, and other applications. It currently has negative earnings. This segment sells its products to distributors, retailers, and customers.

Lifeway Foods, Inc. manufactures and sells probiotic, cultured, and functional dairy health food products in the United States and internationally. The company has market cap of $104.64 million. The companyÂ’s primary product includes drinkable kefir, a fermented dairy product, in varies organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, BioKefir, and kefir with oats. It has a 55.81 P/E ratio. It also offers ProBugs line of kefir products in drinkable, frozen, and freeze dried formats for children; frozen kefir in bars and pint-size containers; and European-style soft cheeses.

Investors sentiment increased to 2.78 in 2017 Q3. Its up 1.20, from 1.58 in 2017Q2. It increased, as 4 investors sold Lifeway Foods, Inc. shares while 8 reduced holdings. 4 funds opened positions while 15 raised stakes. 2.64 million shares or 1.11% less from 2.67 million shares in 2017Q2 were reported. Fmr Ltd Liability reported 0% stake. California Employees Retirement Sys holds 0% or 49,100 shares. Deutsche Bancorp Ag invested in 0% or 5,357 shares. 208,136 are held by Blackrock. Ameritas Prns stated it has 0% of its portfolio in Lifeway Foods, Inc. (NASDAQ:LWAY). Morgan Stanley has 6,162 shares for 0% of their portfolio. Vanguard Gru owns 235,283 shares. Dimensional Fund Advsr Limited Partnership holds 0% in Lifeway Foods, Inc. (NASDAQ:LWAY) or 364,548 shares. Teton invested in 162,931 shares. Bridgeway Cap has invested 0.01% of its portfolio in Lifeway Foods, Inc. (NASDAQ:LWAY). Financial And Inv Mgmt Gp owns 15,565 shares. Nationwide Fund Advsrs invested in 0% or 3,170 shares. California State Teachers Retirement Systems holds 0% or 8,282 shares in its portfolio. Northern Trust reported 0% stake. Amer Interest Group Inc invested in 3,150 shares.

Since December 13, 2017, it had 0 buys, and 2 selling transactions for $142,952 activity. $17,180 worth of stock was sold by SMOLYANSKY JULIE on Wednesday, December 13. 15,209 Lifeway Foods, Inc. (NASDAQ:LWAY) shares with value of $125,772 were sold by SMOLYANSKY LUDMILA.

The stock increased 0.76% or $0.32 during the last trading session, reaching $42.49. About 1.12M shares traded. Cree, Inc. (CREE) has risen 2.53% since March 14, 2017 and is uptrending. It has underperformed by 14.17% the S&P500.

Fairpointe Capital Llc holds 3.3% of its portfolio in Cree, Inc. for 5.91 million shares. Robecosam Ag owns 657,000 shares or 1.43% of their US portfolio. Moreover, Horrell Capital Management Inc. has 1.32% invested in the company for 85,000 shares. The Connecticut-based Amg Funds Llc has invested 1.18% in the stock. Lapides Asset Management Llc, a Connecticut-based fund reported 140,100 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: